Hyperinsulinemia in T2D increases circulating insulin-like growth factor (IGF)-1 levels, activating downstream signaling cascades that enhance prostate cancer cell proliferation, survival, and metastasis via augmented glucose uptake and suppression of apoptosis [11,12]. The gene discussed is IGF1; the disease is prostate cancer.